Hims peptide FDA rumors point to Category 1 push
Newsdesk reports social-media rumors that the FDA plans to move peptides, including BPC-157 and TB-500, to Category 1 before end of October; no confirmation or details were supplied.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.